Shopping Cart
Remove All
Your shopping cart is currently empty
ZJY-54 is an orally active dual inhibitor targeting EGFR/LSD1, with IC50 values of 3.8 nM and 0.6 μM, respectively. It inhibits the proliferation of non-small cell lung cancer cells, induces the accumulation of H3K4me2 and H3K9me2, and suppresses the phosphorylation of EGFR signaling. ZJY-54 exhibits antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | ZJY-54 is an orally active dual inhibitor targeting EGFR/LSD1, with IC50 values of 3.8 nM and 0.6 μM, respectively. It inhibits the proliferation of non-small cell lung cancer cells, induces the accumulation of H3K4me2 and H3K9me2, and suppresses the phosphorylation of EGFR signaling. ZJY-54 exhibits antitumor activity. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.